DK163175C - Synergistisk farmaceutisk kombinationspraeparat af vaevs-plasminogenaktivator, t-pa, og oxypurinol - Google Patents

Synergistisk farmaceutisk kombinationspraeparat af vaevs-plasminogenaktivator, t-pa, og oxypurinol

Info

Publication number
DK163175C
DK163175C DK127187A DK127187A DK163175C DK 163175 C DK163175 C DK 163175C DK 127187 A DK127187 A DK 127187A DK 127187 A DK127187 A DK 127187A DK 163175 C DK163175 C DK 163175C
Authority
DK
Denmark
Prior art keywords
oxypurinol
vegetable
plasminogen activator
pharmaceutical combination
combination preparation
Prior art date
Application number
DK127187A
Other languages
Danish (da)
English (en)
Other versions
DK127187A (da
DK163175B (da
DK127187D0 (da
Inventor
Donald H Namm
Thomas Spector
Henry Berger
Crist J Frangakis
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868606283A external-priority patent/GB8606283D0/en
Priority claimed from GB868623835A external-priority patent/GB8623835D0/en
Priority claimed from GB878701976A external-priority patent/GB8701976D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK127187D0 publication Critical patent/DK127187D0/da
Publication of DK127187A publication Critical patent/DK127187A/da
Publication of DK163175B publication Critical patent/DK163175B/da
Application granted granted Critical
Publication of DK163175C publication Critical patent/DK163175C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49Urokinase; Tissue plasminogen activator

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK127187A 1986-03-13 1987-03-12 Synergistisk farmaceutisk kombinationspraeparat af vaevs-plasminogenaktivator, t-pa, og oxypurinol DK163175C (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB868606283A GB8606283D0 (en) 1986-03-13 1986-03-13 Cell protection
GB8606283 1986-03-13
GB868623835A GB8623835D0 (en) 1986-10-03 1986-10-03 Cell protection
GB8623835 1986-10-03
GB878701976A GB8701976D0 (en) 1987-01-29 1987-01-29 Pharmaceutical combinations
GB8701976 1987-01-29

Publications (4)

Publication Number Publication Date
DK127187D0 DK127187D0 (da) 1987-03-12
DK127187A DK127187A (da) 1987-09-14
DK163175B DK163175B (da) 1992-02-03
DK163175C true DK163175C (da) 1992-06-22

Family

ID=27262953

Family Applications (1)

Application Number Title Priority Date Filing Date
DK127187A DK163175C (da) 1986-03-13 1987-03-12 Synergistisk farmaceutisk kombinationspraeparat af vaevs-plasminogenaktivator, t-pa, og oxypurinol

Country Status (6)

Country Link
EP (1) EP0239289B1 (fr)
AU (1) AU598239B2 (fr)
CA (1) CA1282002C (fr)
DE (1) DE3768109D1 (fr)
DK (1) DK163175C (fr)
NZ (1) NZ219598A (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3839826A1 (de) * 1988-11-25 1990-05-31 Henning Berlin Gmbh Alkali- und erdalkalisalze des oxipurinols in amorpher oder kristalliner form als mittel zur behandlung von hyperurikaemie und gicht
US5200176A (en) * 1989-10-06 1993-04-06 Genentech, Inc. Method for protection of ischemic tissues using tumor nerosis factor
US5370870A (en) * 1989-10-06 1994-12-06 Genentech, Inc. Method for protection against reactive oxygen species

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661469A (en) * 1984-08-08 1987-04-28 Survival Technology, Inc. t-PA composition capable of being absorbed into the blood stream and method of administration
DE3586845T2 (de) * 1984-08-08 1993-04-01 Survival Technology Absorptionsverbesserer.

Also Published As

Publication number Publication date
DE3768109D1 (de) 1991-04-04
EP0239289B1 (fr) 1991-02-27
CA1282002C (fr) 1991-03-26
DK127187A (da) 1987-09-14
EP0239289A1 (fr) 1987-09-30
DK163175B (da) 1992-02-03
DK127187D0 (da) 1987-03-12
AU6997287A (en) 1987-09-17
NZ219598A (en) 1990-05-28
AU598239B2 (en) 1990-06-21

Similar Documents

Publication Publication Date Title
DK87886D0 (da) Thiazolidinderivater, deres fremstilling og anvendelse
DK166007C (da) Farvet naeringsmiddelpraeparat, isaer til dekorationsbrug og fremgangsmaade til fremstilling af praeparatet
NO862095L (no) Farmasoeytiske preparater inneholdende vevsplasmnogenaktivitator og fremgangsmaate for deres fremstilling.
DK273689D0 (da) 4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler
DE3769122D1 (de) Nitro-derivate von 2-iminoimidazolidinen und 2-iminotetrahydropyrimidinen.
NO862096L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator.
DK424084A (da) Praeparat med foroeget collagenolytisk aktivitet og farmaceutiske midler indeholdende dette praeparat
DK288785A (da) Benzensulfonamido-derivater til terapeutisk anvendelse og fremgangsmaade til fremstilling af saadanne derivater
DK237187D0 (da) Farmaceutisk anvendelse af t-pa
DK96787A (da) Human vaevs-plasminogenaktivator
NO875232D0 (no) Stabile preparater av ricin-toksin-a-kjede og av rta-immunokonjugater og stabilisator-utsorteringsmetoder derav.
TR24895A (tr) PIRIMIDIN TüREVLERI,BUNLARIN ISTIHSAL EDILMESI VE KULLANILMASI
DK202687D0 (da) Vaevs-plasminogen-aktivator (tpa)-derivat og dets fremstilling
NO165494C (no) Aminosalter av lignosulfonater og anvendelse derav.
DK396187D0 (da) Di- og tripeptider, deres fremstilling og anvendelse
DK219685A (da) Heterocycliske forbindelser, deres fremstilling og anvendelse som laegemidler
DE3780506D1 (de) Reinigung des einkettigen und zweikettigen gewebeplasminogenaktivators.
NO167154C (no) Nitrogenholdige esterpolyoler, deres fremstilling og anvendelse.
DK284688A (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler
DK130390D0 (da) Praeparat af i prokaryonter udtrykt plasminogenaktivator
NO168055C (no) Fremgangsmaate for fremstilling av human vevplasminogenaktivator og urokinase-type plasminogenaktivator.
DK127187D0 (da) Farmaceutisk kombination af t-pa og oxypurinol
DK14987A (da) Fluorerede diaminoalkylderivater, deres fremstilling og anvendelse
DK316386A (da) Terapeutisk aktive benzamider og fremgangsmaade til fremstilling af saadanne
DK162086A (da) Laegemiddel indeholdende vaevs-plasminogenaktivator, dets fremstilling og anvendelse